Citations

Clear

1526 citation(s) found for "Sun, D".

Gender-Related Difference in Left Ventricular Diastolic Elastance During Exercise in Patients With Diabetes Mellitus
Ha, Jong‐Won , Park, Sungha , Choi, Eui‐Young , Seo, Hye-Sun, Shim, Chi Young , Ahn, Jeong‐Ah , Lee, Se-Wha, Rim, Se‐Joong , Oh, Jae K. , Chung, Namsik, Lee, Hyun‐Chul , Kim, Jin‐Man

Mayo Clinic

Circulation Journal | August 25, 2008 | Volume: 72 | Issue: 9 | Pages: 1443-1448

10.1253/circj.cj-07-1028 | PMID 18724019 Get It

Journal-related and Other Special Activities at the 2008 American Society of Anesthesiologists Annual Meeting
Lerman, Jerrold , Kharasch, Evan D. , Warner, Mark A. , Jevtovic‐Todorovic, Vesna , Patel, Piyush M. , Sun, Lena S. , Eisenach, James C. , Jevtović‐Todorović, Vesna

Mayo Clinic

Anesthesiology | August 15, 2008 | Volume: 109 | Issue: 3 | Pages: 365-370

10.1097/aln.0b013e318183452b | PMID 18754137 Get It

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia
Lee, Stephanie J. , Kukreja, Manisha, Szer, Jeff , Arora, Mukta , Woolfrey, Ann E. , Cervantes, Francisco , Halter, Joerg , Marks, David I. , Olavarría, Eduardo, Stadtmauer, Edward A. , Abecasis, Manuel, Gupta, Vikas , Khoury, H. Jean, Hale, Gregory A., Rizzieri, David A. , Antin, Joseph H. , Bolwell, Brian J., Carabasi, Matthew, Copelan, Edward A. , İlhan, Osman , Litzow, Mark R. , Schouten, H, Zander, Axel R., Horowitz, Mary M. , Halter, Jörg , Wang, Tao , Giralt, Sergio , Champlin, Richard E. , Gale, Robert Peter , Keating, Armand , McCarthy, Philip L. , George, Biju , Liesveld, Jane L. , Maziarz, Richard Thomas , Gupta, Vikas , Lee, Stephanie J

Mayo Clinic

Blood | July 30, 2008 | Volume: 112 | Issue: 8 | Pages: 3500-3507

10.1182/blood-2008-02-141689 | PMID 18664621 Get It

AbstractImatinib mesylate (IM, Gleevec) has largely supplanted allogeneic hematopoietic cell transplantation (HCT) as first line therapy for chronic myeloid leukemia (CML). Nevertheless, many people with CML eventually undergo HCT, raising the question of whether prior IM therapy impacts HCT success. Data from the Center for International Blood and Marrow Transplant Research on 409 subjects treated with IM before HCT (IM+) and 900 subjects who did not receive IM before HCT (IM−) were analyzed. Among patients in first chronic phase, IM therapy before HCT was associated with better survival but no statistically significant differences in treatment-related mortality, relapse, and leukemia-free survival. Better HLA-matched donors, use of bone marrow, and transplantation within one year of diagnosis were also associated with better survival. A matched-pairs analysis was performed and confirmed a higher survival rate among first chronic phase patients receiving IM. Among patients transplanted with advanced CML, use of IM before HCT was not associated with treatment-related mortality, relapse, leukemia-free survival, or survival. Acute graft-versus-host disease rates were similar between IM+ and IM− groups regardless of leukemia phase. These results should be reassuring to patients receiving IM before HCT.
P3‐004: Past hormone replacement use attenuates the cognitive deficits in Alzheimer's disease patients
Bottiggi, Kara A., Connor, Donald J., Comer, James P., Herring, Anne M., Caselli, Richard J., Bottiggi, Kara A., Baxter, Leslie C.

Mayo Clinic

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_16 | Pages: No page available

10.1016/j.jalz.2008.05.1567 Get It

P3‐108: Subjective memory complaints in the healthy elderly
Belden, Christine M. , Connor, Donald J., Adler, Charles, Sabbagh, Marwan N.

Mayo Clinic

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_17 | Pages: No page available

10.1016/j.jalz.2008.05.1673 Get It

Modeling Nonlinear Manifolds with Mixtures of Localized Principal Subspaces under a Self-Organizing Framework
Zheng, Huicheng , Shen, Wei , Dai, Qionghai , Hu, Sanqing

Mayo Clinic

2008 IEEE International Conference on Networking, Sensing and Control | May 20, 2008 | Volume: No volume available | Issue: No issue available | Pages: 654-659

10.1109/icnsc.2008.4525298 Get It

Pathologic findings in prospectively ascertained essential tremor subjects
Shill, Holly A. , Connor, Donald J., Caviness, John N., Hentz, Joseph G. , Beach, Thomas G. , Adler, Charles H. , Sabbagh, Marwan Noel

Mayo Clinic

Neurology | May 4, 2008 | Volume: 70 | Issue: 16_part_2 | Pages: 1452-1455

10.1212/01.wnl.0000310425.76205.02 | PMID 18413570 Get It

Bile Acid Exposure Up-regulates Tuberous Sclerosis Complex 1/Mammalian Target of Rapamycin Pathway in Barrett's-Associated Esophageal Adenocarcinoma
Yen, Chia-Jui , Izzo, Julie, Lee, Dung‐Fang , Guha, Sushovan , Wei, Yongkun , Wu, Tsung‐Teh, Kuo, Hsu-Ping, Hsu, Jung-Mao , Sun, Hui-Lung, Chou, Chao‐Kai , Buttar, Navtej , Wang, Kenneth K. , Huang, Peng , Hung, Mien‐Chie , Chen, Chun‐Te , Kuo, Hsu-Ping, Ajani, Jaffer A.

Mayo Clinic

Cancer Research | April 15, 2008 | Volume: 68 | Issue: 8 | Pages: 2632-2640

10.1158/0008-5472.can-07-5460 | PMID 18413730 Get It

Abstract Barrett's esophagus, a columnar metaplasia of the lower esophagus epithelium related to gastroesophageal reflux disease, is the strongest known risk factor for the development of esophageal adenocarcinoma (EAC). Understanding the signal transduction events involved in esophageal epithelium carcinogenesis may provide insights into the origins of EAC and may suggest new therapies. To elucidate the molecular pathways of bile acid–induced tumorigenesis, the newly identified inflammation-associated signaling pathway involving IκB kinases β (IKKβ), tuberous sclerosis complex 1 (TSC1), and mammalian target of rapamycin (mTOR) downstream effector S6 kinase (S6K1) was confirmed to be activated in immortalized Barrett's CPC-A and CPC-C cells and esophageal cancer SEG-1 and BE3 cells. Phosphorylation of TSC1 and S6K1 was induced in response to bile acid stimulation. Treatment of these cells with the mTOR inhibitor rapamycin or the IKKβ inhibitor Bay 11-7082 suppressed bile acid–induced cell proliferation and anchorage-independent growth. We next used an orthotopic rat model to evaluate the role of bile acid in the progression of Barrett's esophagus to EAC. Of interest, we found high expression of phosphorylated IKKβ (pIKKβ) and phosphorylated S6K1 (pS6K1) in tumor tissues and the Barrett's epithelium compared with normal epithelium. Furthermore, immunostaining of clinical EAC tissue specimens revealed that pIKKβ expression was strongly correlated with pS6K1 level. Together, these results show that bile acid can deregulate TSC1/mTOR through IKKβ signaling, which may play a critical role in EAC progression. In addition, Bay 11-7082 and rapamycin may potentially be chemopreventive drugs against Barrett's esophagus–associated EAC. [Cancer Res 2008;68(8):2632–40]
Origins and Prevalence of the American Founder Mutation of MSH2
Baze, Mark E., Walsh, Kyle M. , Liyanarachchi, Sandya , Fix, Dan, Schunemann, Victoria , Comeras, Ilene, Deacon, Molly, Lynch, Jane F., Gong, Gordon, Thomas, Brittany C. , Thibodeau, Stephen N. , Lynch, Henry T., Chapelle, Albert de la , Clendenning, Mark , Sun, Shuying , Hampel, Heather

Mayo Clinic

Cancer Research | April 1, 2008 | Volume: 68 | Issue: 7 | Pages: 2145-2153

10.1158/0008-5472.can-07-6599 | PMID 18381419 Get It

Abstract Large germline deletions within the mismatch repair gene MSH2 account for a significant proportion (up to 20%) of all deleterious mutations of this gene which are associated with Lynch syndrome. An exons 1 to 6 deletion of MSH2, originally reported in nine families, has been associated with a founding event within the United States, which genealogic studies had previously dated to 1727, and the number of present day carriers was estimated to be 18,981. Here, we report the development of a robust multiplex PCR which has assisted in the detection of 32 new families who carry the MSH2 American Founder Mutation (AFM). By offering testing to family members, 126 carriers of the AFM have been identified. Extensive genealogic studies have connected 27 of the 41 AFM families into seven extended pedigrees. These extended families have been traced back to around the 18th century without any evidence of further convergence between them. Characterization of the genomic sequence flanking the deletion and the identification of a common disease haplotype of between 0.6 and 2.3 Mb in all probands provides evidence for a common ancestor between these extended families. The DMLE+2.2 software predicts an age of ∼500 years (95% confidence interval, 425–625) for this mutation. Taken together, these data are suggestive of an earlier founding event than was first thought, which likely occurred in a European or a Native American population. The consequences of this finding would be that the AFM is significantly more frequent in the United States than was previously predicted. [Cancer Res 2008;68(7):2145–53]
Wnt3a Regulates the Development of Cardiac Neural Crest Cells by Modulating Expression of Cysteine-Rich Intestinal Protein 2 in Rhombomere 6
Sun, Xiaojing , Zhang, Ruilin , Lin, Xueying , Xu, Xiaolei

Mayo Clinic

Circulation Research | February 23, 2008 | Volume: 102 | Issue: 7 | Pages: 831-839

10.1161/circresaha.107.166488 | PMID 18292601 Get It

The cardiac neural crest is a subpopulation of neural crest cells (NCCs) that originates from the dorsal neural tube and later migrates to the heart and pharyngeal arch (PA), where they contribute to distinct aspects of cardiogenesis and PA patterning. Wnt family members have been implicated in general neural crest induction; however, the molecular mechanisms underlying the specification of distinct cell types such as cardiac NCCs remain unclear. Here, we have identified cysteine-rich intestinal protein 2 ( crip2 ), a gene encoding for a LIM domain–containing protein, as a novel marker for cardiac NCCs in zebrafish. We observed a dynamic expression pattern for crip2 , with expression being detected in the premigratory NCCs in rhombomere 6 (r6), migrating NCCs, ventricular cardiomyocytes, and aortic vessels in PAs 3 to 6. Interestingly, expression of wnt3a was detected in regions of the dorsal neural tube encompassing r6, and reduction of wnt3a led to disrupted expression of crip2 in r6, abnormal migration of NCCs, and defective cardiac function, as well as PA development. Furthermore, these phenotypes could be recapitulated by reduction of crip2 and rescued by overexpression of crip2 . In summary, our data suggest a specific role for Wnt3a in the development of cardiac NCCs. We propose that this function of wnt3a in r6 is partially mediated by crip2 expression in the premigratory cardiac NCCs, which subsequently affects cardiac function and PA patterning.